EXHIBIT 99.5 JOINT FILER INFORMATION FOR ORACLE INVESTMENT MANAGEMENT

Exhibit 99.5

FORM 4 JOINT FILER INFORMATION

(Attachment to Form 4 in accordance with instruction 4(b)(v))

Check this box if no longer subject to
Section 16: [ X ]

Name and Address: Oracle Investment Management, Inc.
200 Greenwich Avenue, 3rd Floor
Greenwich, CT 06830

Issuer and Ticker Symbol: Access Pharmaceuticals, Inc. ("ACCP")

Date of Earliest Transaction: 2/12/08

Relationship to Issuer: 10% Owner

Designated Filer: Larry N. Feinberg

TABLE I INFORMATION
Title of Security: Common Stock
Transaction Date: 2/12/2008
Transaction Code: S
Securities Disposed: 29,736
Acquired or Disposed: D
Price: $3.15
Ownership Form: I
Amount Beneficially Owned After
Transaction (14)
Nature of Indirect Beneficial
Ownership (13)

TABLE II INFORMATION
Title of Derivative Security: Preferred Stock
Conversion or Exercise Price of
Derivative Security (6)
Transaction Date: 11/10/2007
Transaction Code: S (7)
Securities Acquired: 86
Date Exercisable and Expiration Date: (6)
Title of Underlying Securities: Common Stock
Amount of Underlying Securities: 240,000
Price of Derivative Securities: $6,885.00
Number Beneficially Owned 86
Ownership Form: I
Nature of Indirect Beneficial
Ownership (13)




Title of Derivative Security: Warrants
Conversion or Exercise Price of
Derivative Security (9)
Transaction Date: 11/10/2007
Transaction Code: S
Securities Acquired: 143,773
Date Exercisable and Expiration Date: (9)
Title of Underlying Securities: Common Stock
Amount of Underlying Securities: 143,773
Price of Derivative Securities: (7)
Number Beneficially Owned 143,773
Ownership Form: I
Nature of Indirect Beneficial
Ownership (13)

Explanation of Responses:

(6), (7), (9), (13) and (14): See
Exhibit 99.1.


Signature: ORACLE INVESTMENT MANAGEMENT, INC.


By: /s/ Larry N. Feinberg
---------------------------------
Name: Larry N. Feinberg
Title: President

Date: June 10, 2008